Manufacture of Autologous CD34(+) Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases

To ensure comparable grafts for autologous hematopoietic cell transplantation (HCT) in the National Institute of Allergy and Infectious Diseases–sponsored Investigational New Drug protocols for multiple sclerosis (HALT-MS) and systemic sclerosis (SCOT), a Drug Master File approach to control manufac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Keever-Taylor, Carolyn A., Heimfeld, Shelly, Steinmiller, Kaitlyn C., Nash, Richard A., Sullivan, Keith M., Czarniecki, Christine W., Granderson, Tomeka C., Goldstein, Julia S., Griffith, Linda M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5761325/
https://ncbi.nlm.nih.gov/pubmed/28602891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.05.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados